Inventor · disambiguated record
Wei-Hsien Ho
Also filed as: HO WEI-HSIEN
26 granted patents·13 pending applications·360 citations·filing 1994–2025
96Inventor score
Top patents by PatentIndex Score
39 records- 0198US8871908B2Antibodies specific for Trop-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2012·Granted Oct 28, 2014·86 cites·26 claims
- 0296US9399074B2Antibodies specific for trop-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2014·Granted Jul 26, 2016·19 cites·19 claims
- 0395US9527926B2Heterodimeric proteins and methods for producing and purifying themHO WEI-HSIEN·Filed 2011·Granted Dec 27, 2016·44 cites·10 claims
- 0494US7927594B2Antibodies directed against amyloid-beta peptideRINAT NEUROSCIENCE CORP·Filed 2005·Granted Apr 19, 2011·24 cites·21 claims
- 0594US7763250B2Antibodies directed against amyloid-beta peptide and nucleic acids encoding sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Jul 27, 2010·23 cites·29 claims
- 0691US9708405B2Anti-CXCR4 antibodies and antibody-drug conjugatesPFIZER·Filed 2014·Granted Jul 18, 2017·17 cites·45 claims
- 0789US11667699B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jun 6, 2023·3 cites·93 claims
- 0888US12258410B2Anti-SIRPα antibodies and methods of use thereofALECTOR LLC·Filed 2024·Granted Mar 25, 2025·0 cites·76 claims
- 0985US7807165B2Antibodies directed against amyloid-beta peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2005·Granted Oct 5, 2010·5 cites·68 claims
- 1083US5756456AMethods involving sensory and motor neuron derived factor (SMDF)GENENTECH INC·Filed 1995·Granted May 26, 1998·44 cites·17 claims
- 1182US11319373B2Anti-SIRPA antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted May 3, 2022·1 cites·83 claims
- 1280US8425905B2Antibodies directed against amyloid-beta peptide and methods using sameROSENTHAL ARNON·Filed 2012·Granted Apr 23, 2013·3 cites·18 claims
- 1380US5667780AAntibodies to SMDFGENENTECH INC·Filed 1995·Granted Sep 16, 1997·42 cites·12 claims
- 1479US12247073B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Mar 11, 2025·1 cites·84 claims
- 1579US11976119B2Anti-SIRPa antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted May 7, 2024·0 cites·91 claims
- 1679US8268593B2Polynucleotides encoding antibodies directed against amyloid-beta peptideROSENTHAL ARNON·Filed 2010·Granted Sep 18, 2012·3 cites·35 claims
- 1779US5763213ASensory and motor neuron derived factor (SMDF)GENENTECH INC·Filed 1995·Granted Jun 9, 1998·26 cites·31 claims
- 1876US10421815B2Anti-CXCR4 antibodies and antibody-drug conjugatesPFIZER·Filed 2018·Granted Sep 24, 2019·1 cites·4 claims
- 1976US10100114B2Antibodies specific for TROP-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2016·Granted Oct 16, 2018·1 cites·9 claims
- 2076US8398978B2Antibodies directed against amyloid-beta peptide and methods using sameROSENTHAL ARNON·Filed 2010·Granted Mar 19, 2013·2 cites·19 claims
- 2176US2022249657A1Anti-pd-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2022·Application pending·0 cites
- 2275US10144781B2Anti-CXCR4 antibodies and antibody-drug conjugatesPFIZER·Filed 2017·Granted Dec 4, 2018·1 cites·4 claims
- 2375US2025179189A1Anti-SIRPa Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 2474US10927178B2Anti-CXCR4 antibodies and antibody-drug conjugatesPFIZER·Filed 2019·Granted Feb 23, 2021·0 cites·3 claims
- 2570US11338035B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2020·Granted May 24, 2022·0 cites·15 claims
- 2667US2024383997A1Proteins comprising blood brain barrier (bbb)-binding domains within constant domainsALECTOR LLC·Filed 2024·Application pending·0 cites
- 2766US2024076362A1Anti-ms4a4a antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 2865US5770567ASensory and motor neuron derived factor (SMDF)GENENTECH INC·Filed 1994·Granted Jun 23, 1998·14 cites·22 claims
- 2964US11091544B2Antibodies specific for Trop-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2018·Granted Aug 17, 2021·0 cites·8 claims
- 3062US2025270319A1Anti-cd33 antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 3161US12227568B2Anti-Siglec-7 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Feb 18, 2025·0 cites·38 claims
- 3261US2024279341A1Bispecific anti-mertk and anti-pdl1 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 3361US2024279358A1Monovalent anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 3460US2025333523A1Anti-IL18 Binding Protein Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 3559US2013236451A1Antibodies directed against amyloid-beta peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2013·Application pending·0 cites
- 3659US2025145709A1Anti-siglec-7 antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 3753US2016096884A1Antibodies directed against amyloid-beta peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2015·Application pending·0 cites
- 3847US2025270339A1Transferrin receptor antigen-binding domains and uses thereforALECTOR LLC·Filed 2025·Application pending·0 cites
- 3944US2025270343A1Anti-gpnmb antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →